Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis
NCT03068234
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Systemic Sclerosis
Interventions
DRUG:
Pirfenidone
DRUG:
Placebo oral capsule
DRUG:
Steroids
Sponsor
RenJi Hospital